- Generic name
- Letrozole
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Manufactured by
- One Pharma Ltd.
Lemirol Tablet
About Lemirol 2.5 mg Tablet
Lemirol 2.5 mg tablet is a medicine made by One Pharma Ltd. It is a hormonal chemotherapy medicine, not a general painkiller or vitamin, and it should only be used under the care of a qualified cancer specialist.
There are 7 brands of Letrozole listed in Bangladesh. The lowest listed price is Ovazol 2.5 mg Tablet at ৳ 40.00 per unit.
What is Lemirol 2.5 mg Tablet?
Made by One Pharma Ltd., Lemirol is a tablet whose active ingredient is Letrozole. Letrozole is an aromatase inhibitor: it reduces the amount of oestrogen the body makes, which can slow the growth of cancers that depend on oestrogen. Regular follow-up is important to monitor the response to treatment. The doctor decides the dose and duration of treatment based on the patient's condition.
Uses of Lemirol
It is a hormonal chemotherapy medicine, not a general painkiller or vitamin, and it should only be used under the care of a qualified cancer specialist. The doctor will confirm whether this medicine is appropriate based on the cancer type and menopausal status. Lemirol is used for the first-line treatment of advanced or metastatic breast cancer in post-menopausal women when the tumour is hormone receptor positive or its receptor status is unknown. Ask your doctor whether it is right for your condition.
How to use Lemirol
The tablet is usually taken by mouth, and your doctor will decide the dose and how long you continue treatment. Swallow the tablet with water. You can take it with or without food. If you miss a dose, ask your doctor or pharmacist what to do. Tell your doctor about any other medicines you take.
Side effects of Lemirol
Dizziness, weight gain and itching are seen less often. Many are linked to the low estrogen levels the medicine causes. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
Discuss all your medical conditions and medicines with your doctor. It is also not recommended for people with severe liver problems. Ask your doctor first about any health concern, and keep all follow-up appointments.
Frequently asked questions
What is Lemirol used for?
It is a hormonal chemotherapy medicine, not a general painkiller or vitamin, and it should only be used under the care of a qualified cancer specialist. The doctor will confirm whether this medicine is appropriate based on the cancer type and menopausal status.
How do I use Lemirol correctly?
The tablet is usually taken by mouth, and your doctor will decide the dose and how long you continue treatment. Swallow the tablet with water.
What are the side effects of Lemirol?
Dizziness, weight gain and itching are seen less often. Many are linked to the low estrogen levels the medicine causes.
Who should be careful with Lemirol?
Discuss all your medical conditions and medicines with your doctor. It is also not recommended for people with severe liver problems.
Indications
Pharmacology
In healthy postmenopausal women, single doses of 0.1, 0.5 and 2.5mg letrozole suppress serum oestrone and oestradiol by 75-78% and 78% from baseline respectively. Maximum suppression is achieved in 48-78 hours. In post-menopausal patients, with advanced breast cancer, daily doses of 0.1 to 5mg suppress plasma concentration of oestradiol, oestrone, and oestrone sulphate by 78-95% from baseline in all patients treated. Letrozole had no effect on plasma androgen concentrations (androstenedione and testosterone) among healthy postmenopausal women after single doses of 0.1, 0.5 and 2.5mg indicating that the blockade of estrogen biosynthesis does not lead to accumulation of androgenic precursors. Impairment of adrenal steroidogenesis has not been observed.
Pharmacokinetics: Letrozole is rapidly and completely absorbed from the gastrointestinal tract (absolute bioavailability 99.9%). Food slightly decreases the rate of absorption, but the extent of absorption remains unchanged. The minor effect of the absorption rate is not considered to be of clinical relevance and therefore letrozole may be taken after, with or before food. Plasma protein binding of letrozole is approximately 60%, mainly to albumin (55%). The concentration of letrozole in erythrocytes is about 80% of that in plasma. Metabolic clearance to a pharmacologically inactive carbinol metabolite is the major elimination pathway of letrozole but is relatively slow when compared to hepatic blood flow. The cytochrome P450 isoenzymes 3A4 and 2A6 were found to be capable of converting letrozole to this metabolite in vitro but their individual contributions to letrozole metabolism in vivo have not been established. The apparent terminal elimination half-life in plasma is about 2 days. After daily administration of 2.5mg of letrozole, steady-state levels are reached within 2 to 6 weeks.
Dosage & Administration
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Letrozole
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.